Optimal therapy in Gaucher disease

by Ozlem Goker-Alpan
Published 2010-07-01

Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease

by Renuka P. Limgala, Ozlem Goker-Alpan
Published 2020-03-01

Gaucher Disease and the Synucleinopathies

by Kathleen S. Hruska, Ozlem Goker-Alpan, Ellen Sidransky
Published 2006-01-01

Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases.

by Margarita M Ivanova, Erk Changsila, Chidima Iaonou, Ozlem Goker-Alpan
Published 2019-01-01

The Interaction of Innate and Adaptive Immunity and Stabilization of Mast Cell Activation in Management of Infusion Related Reactions in Patients with Fabry Disease

by Renuka P. Limgala, Jaqueline Fikry, Vasudha Veligatla, Ozlem Goker-Alpan
Published 2020-09-01

TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease

by Margarita Ivanova, Julia Dao, Lauren Noll, Jacqueline Fikry, Ozlem Goker-Alpan
Published 2021-05-01

Rapid Clathrin-Mediated Uptake of Recombinant α-Gal-A to Lysosome Activates Autophagy

by Margarita M. Ivanova, Julia Dao, Neil Kasaci, Benjamin Adewale, Jacqueline Fikry, Ozlem Goker-Alpan
Published 2020-05-01

Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey

by Ida Vanessa D. Schwartz, Özlem Göker-Alpan, Priya S. Kishnani, Ari Zimran, Lydie Renault, Zoya Panahloo, Patrick Deegan
Published 2018-03-01

Pregnancy Outcomes in Late Onset Pompe Disease

by Ozlem Goker-Alpan, Vellore G. Kasturi, Maninder K. Sohi, Renuka P. Limgala, Stephanie L. Austin, Tabitha Jennelle, Maryam Banikazemi, Priya S. Kishnani
Published 2020-09-01

Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.

by Renuka Pudi Limgala, Chidima Ioanou, Matthew Plassmeyer, Mark Ryherd, Lina Kozhaya, Lauren Austin, Cem Abidoglu, Derya Unutmaz, Oral Alpan, Ozlem Goker-Alpan
Published 2016-01-01

Selective screening for lysosomal storage disorders in a large cohort of minorities of African descent shows high prevalence rates and novel variants

by Renuka Pudi Limgala, Vyacheslav Furtak, Margarita M. Ivanova, Erk Changsila, Floyd Wilks, Marie N. Fidelia‐Lambert, Ozlem Goker‐Alpan, Marjorie C. Gondré‐Lewis
Published 2021-05-01

A pilot study of omalizumab in eosinophilic esophagitis.

by Denise Loizou, Benjamin Enav, Edina Komlodi-Pasztor, Pamela Hider, Julie Kim-Chang, Laura Noonan, Tabitha Taber, Suhasini Kaushal, Renuka Limgala, Margaret Brown, Raavi Gupta, Nader Balba, Ozlem Goker-Alpan, Amer Khojah, Oral Alpan
Published 2015-01-01

Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase.

by David G Warnock, Daniel G Bichet, Myrl Holida, Ozlem Goker-Alpan, Kathy Nicholls, Mark Thomas, Francois Eyskens, Suma Shankar, Mathews Adera, Sheela Sitaraman, Richie Khanna, John J Flanagan, Brandon A Wustman, Jay Barth, Carrolee Barlow, Kenneth J Valenzano, David J Lockhart, Pol Boudes, Franklin K Johnson
Published 2015-01-01